Medigen Biotechnology Corp. (TPEX: 3176)
Health Care · Biotechnology · TW
NT$—
— today · — 1Y
Medigen Biotechnology Corp. (TPEX: 3176) operates in the Biotechnology industry within the Health Care sector. The company is valued at $168.61M and employs 67 people.
trading between 28.00 and 43.60.
Tweenvest scores Medigen Biotechnology Corp. across four factors: quality 63/100, value 65/100, growth 75/100. Its strongest factor is growth.
3176 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $168.61M
- Revenue (TTM)
- $39.87M
- P/E
- —
- EPS
- -1.81
- Dividend yield
- —
- Beta (5Y)
- 0.30
- 52-week high
- NT$43.60
- 52-week low
- NT$28.00
- Avg volume (3M)
- —
- Shares outstanding
- 139.31M
- Employees
- 67
- Next earnings
- —
About Medigen Biotechnology Corp.
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
- ISIN
- TW0003176004
- Founded
- 1990
- Listed since
- Dec 31, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.SEHK: 2566 | $172.36M | HK$5.64 | -2.51% |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc.SEHK: 1541 | $171.05M | HK$3.13 | -7.54% |
| Dx & Vx Co., Ltd.KOSDAQ: A180400 | $170.59M | ₩2,330.00 | -1.48% |
| HEM Pharma Inc.KOSDAQ: A376270 | $169.45M | ₩31,600.00 | -9.06% |
| Canton Strategic Holdings, Inc.NasdaqCM: CNTN | $168.13M | $2.11 | 0.00% |
| AptaBio Therapeutics Inc.KOSDAQ: A293780 | $165.92M | ₩7,940.00 | +1.79% |
| Burning Rock Biotech LimitedNasdaqGM: BNR | $163.36M | $15.00 | -3.16% |
| GC Cell CorporationKOSDAQ: A144510 | $163.20M | ₩14,600.00 | +0.14% |
Figures last refreshed Oct 11, 2026.